Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study

PLoS One. 2012;7(7):e42330. doi: 10.1371/journal.pone.0042330. Epub 2012 Jul 30.

Abstract

Background: Cardiovascular disease (CVD) is a leading cause of death worldwide, and the number of people at risk is continuously growing. New methods for early risk prediction are therefore needed to actuate prevention strategies before the individuals are diagnosed with CVD. Several studies report that aerobic fitness level, measured as maximal oxygen uptake (VO(2max)), is the single best predictor of future CVD mortality in healthy people. Based on this, we wanted to study differences between healthy individuals with a large difference in VO(2max)-level to identify new biomarkers of low aerobic fitness that may also have potential as early biomarkers of CVD risk.

Methodology/principal findings: Serum samples from 218 healthy individuals with a low VO(2max) (n = 108, 63 women) or high VO(2max) (n = 110, 64 women) were analysed with MR metabolomics. In addition, standard clinical-chemical analyses for glucose, lipids, liver enzymes, micro-CRP, and colorimetric analysis on circulating choline were performed. Individuals in the low VO(2max)-group had increased serum levels of free choline, decreased phosphatidylcholine, increased glucosę and decreased unsaturated fatty acids compared to the individuals in the high VO(2max)-group.

Conclusions/significance: Aerobic fitness dependent differences in serum levels of free choline and phosphatidylcholine are observed. They should be further studied as potential early markers of CVD risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Choline / blood*
  • Exercise*
  • Female
  • Humans
  • Male
  • Oxygen Consumption
  • Reference Values

Substances

  • Choline

Grants and funding

The study was supported by grants from the K.G. Jebsen Foundation, the Norwegian Council on Cardiovascular Disease, St. Olavs Hospital and the Liaison Committee between the St. Olavs Hospital and the Faculty of Medicine, Norwegian University of Science and Technology (NTNU), the Norwegian Research Council Funding for Outstanding Young Investigators, the Royal Norwegian Society of Sciences and Letters (DKNVS) and the Foundation for Cardiovascular Research at St. Olavs Hospital and NTNU. There are no disclosures to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.